Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.806 EUR | -0.66% | -5.45% | -50.25% |
Apr. 04 | AB Science's Reconsideration Request for ALS Treatment Granted Eligibility in Canada | MT |
Apr. 03 | AB Science: reconsideration possible for masitinib in ALS | CF |
Quotes 5-day view
Delayed Quote Deutsche Boerse AG2024-04-23 | 2024-04-24 | 2024-04-25 | 2024-04-26 | |
---|---|---|---|---|
Last | 1.954 € | 1.938 € | 1.818 € | 1.806 € |
Change | +1.35% | -0.82% | -6.19% | -0.66% |
Performance
1 day | -0.66% | ||
1 week | -5.45% | ||
Current month | -28.76% | ||
1 month | -29.18% | ||
3 months | -51.32% | ||
6 months | -16.97% | ||
Current year | -50.25% | ||
1 year | -68.86% | ||
3 years | -88.34% | ||
5 years | -60.99% | ||
10 years | -84.90% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Specialty & Advanced Pharmaceuticals
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-0.66% | -5.45% | -50.25% | -68.86% | 106M | ||
+1.10% | +3.94% | +5.31% | -5.89% | 70.44B | ||
+0.23% | +0.80% | +10.97% | -12.91% | 8.94B | ||
+0.24% | +0.97% | -16.83% | +17.94% | 4.75B | ||
+4.34% | +23.11% | +43.48% | +109.28% | 4.5B | ||
-0.70% | +2.45% | +3.20% | +31.48% | 3.85B | ||
+0.57% | -7.00% | +18.82% | -4.22% | 2.38B | ||
+3.66% | +12.49% | -21.36% | -38.41% | 2.34B | ||
+0.05% | -4.81% | -29.67% | -44.13% | 2.2B | ||
-0.66% | +1.14% | +8.38% | -22.44% | 1.96B | ||
-.--% | -.--% | - | - | 1.64B | ||
+2.59% | +2.28% | +3.90% | -18.18% | 1.65B | ||
+0.82% | +7.56% | +1.14% | -19.57% | 1.25B | ||
+1.41% | +4.82% | +16.02% | +33.77% | 1.01B | ||
+1.54% | +16.53% | -24.30% | -25.83% | 981M | ||
+1.82% | +4.19% | -37.08% | -49.28% | 880M | ||
Average | +1.02% | +3.44% | -4.55% | -7.82% | ||
Weighted average by Cap. | +1.07% | +3.64% | +4.74% | -1.58% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | -50.25% | ||
2023 | -51.82% | ||
2022 | -36.79% | ||
2021 | -33.48% | ||
2020 | +252.06% | ||
2019 | +58.96% | ||
2018 | -61.60% | ||
2017 | -38.65% | ||
2016 | +10.58% | ||
2015 | +7.19% | ||
2014 | -17.03% | ||
2013 | -23.46% | ||
2012 | +239.25% | ||
2011 | -32.12% | ||
2010 | -37.28% |
- Stock Market
- Equities
- AB Stock
- A8D Stock
- Quotes AB Science